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American ginseng root displays the ability to achieve glucose homeostasis both experimentally and
clinically but the unknown mechanism used by ginseng to achieve its therapeutic effects on diabetes
limits its application. Disruption in the insulin secretion of pancreatic b cells is considered the major
cause of diabetes. A mitochondrial protein, uncoupling protein-2 (UCP-2) has been found to play a
critical role in insulin synthesis and b cell survival. Our preliminary studies found that the extracts of
American ginseng inhibit UCP-2 expression which may contribute to the ability of ginseng protecting b
cell death and improving insulin synthesis. Therefore, we hypothesized that ginseng extracts suppress
UCP-2 in the mitochondria of pancreatic b cells, promoting insulin synthesis and anti-apoptosis (a
programmed cell-death mechanism). To test the hypothesis, the serum-deprived quiescent b cells were
cultured with or without interleukin-1b (IL-1b), (200 pg ml
 1, a cytokine to induce b cell apoptosis) and
water extracts of American ginseng (25 mg per 5 ml administered to wells of 0.5 ml culture) for 24 h. We
evaluated effects of ginseng on UCP-2 expression, insulin production, anti-/pro-apoptotic factors Bcl-2/
caspase-9 expression and cellular ATP levels. We found that ginseng suppresses UCP-2, down-regulates
caspase-9 while increasing ATP and insulin production/secretion and up-regulates Bcl-2, reducing
apoptosis. These findings suggest that stimulation of insulin production and prevention of b cell loss by
American ginseng extracts can occur via the inhibition of mitochondrial UCP-2, resulting in increase in
the ATP level and the anti-apoptotic factor Bcl-2, while down-regulation of pro-apoptotic factor
caspase-9 occurs, lowering the occurrence of apoptosis, which support the hypothesis.
Keywords: American ginseng – apoptosis – ATP – b cell – Bcl-2 – caspase – insulin –
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Introduction
As a devastating illness with significant morbidity and
mortality, diabetes mellitus has increased steadily worldwide
(1,2). Type I juvenile diabetes is known as an auto-immune
disease possibly caused by an over-immune reaction resulting
in extensive destruction of the insulin-producing b cells in the
islets of Langerhans in the pancreas (3). While the cause of
type II adult-onset diabetes remains poorly understood, all
patients with type I diabetes and part of type II diabetes require
daily insulin shots, replacement of the destroyed b cell mass
via islets or transplant of pancreas in order to survive (4).
The use of herbal remedies has been on the rise in the United
States (380% over the last 7 years) (3,5–7). Historical
treatment of diabetes utilizes traditional medicine (8,9) and
integrates of ginseng root extracts in tonic form into the diet.
Ginseng root has been used for millennia in ancient Asian
tonics for its restorative and curative properties. American
(Panax quinquefolius L.) and Asian ginsengs (Panax ginseng
CA Meyer) stand as the two widely used species of ginseng
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ginseng exhibits an effect on blood flow and decreases fatigue,
while American ginseng leans towards decreasing aging and
regulating digestion (5). The role of American ginseng has
been shown to facilitate anti-hyperglycemia but whether
American ginseng improves on pancreatic b cell function is
still unknown (10–13).
b cell dysfunction and death are attributed to the inability to
produce sufficient amounts of insulin, which can be caused by
many factors. One possibility contributing to the loss of insulin
would be the gradual loss of b cells, possibly through
programmed cell death (apoptosis) in which cells appear to
shrink, chromatin condenses and DNA is cleaved into pieces at
internucleosomal regions (14). Membrane ‘blebbing’ eventu-
ally leads to the breakdown of the cell into small bodies that
are quickly taken up by neighboring cells without inflamma-
tion. The Bcl-2 proto-oncogene is the most fully characterized
protein substance which plays a key role in regulating
programmed cell death (15–18). In addition, initiation of the
Caspase cascade involves translocation of cytochrome c from
mitochondria to the cytoplasm to activate caspase-9 then
cleave pro-caspase-3, initiating the proteolytic cascade essen-
tial for apoptosis (19). Lack of insulin production results from
a shortage of ATP produced within the mitochondria,
indicating that mitochondrial ATP plays a critical role in
insulin production (20,21).
A mitochondrial protein, uncoupling protein-2 (UCP-2),
uncouples electron transport from ATP production by trans-
porting protons across the inner membrane, suppressing ATP
production. Studies have shown that high levels of UCP-2
negatively regulate insulin secretion in vivo and in vitro by
yielding ATP generation (21–25). Some degree of uncoupling
exists in many if not all cells and tissues and evidence suggests
that uncoupling might be useful in limiting chronic exposure to
harmful reactive oxygen species generated in the mitochondria
but the inefficiency inherent with uncoupling may provide a
significant disadvantage in cellular survival (26,27). Accord-
ingly, studies have shown that even modestly increased levels
of UCP-2 protein reduce cell survival (28).
The purpose of the study is to explore the effects of
American ginseng root extracts on the pancreatic b cell’s
function and survival with a cytokine, interleukin-1b (IL-1b)
induced b cell dysfunction model (29,30). Mechanisms
involved in achieving up-regulated insulin production and
lowered apoptosis levels were determined by evaluating the
activation of ATP, UCP-2, Bcl-2 and caspase-9.
Methods
Ginseng Root Preparation
Sliced American ginseng (Panax quinquefolium L.) root was
purchased from H.S.U Corp. (WI, USA). The ginseng root was
soaked in 10 ml of ddH2O for 24 h at 4 C on a rotator with
gentleshaking. The supernatant appeared yellow. Following
centrifugation, the supernatant was lyophilized to yield the
solid product which was weighed and diluted to yield a final
concentration of 5 mg ml
 1. One lot of ginseng was used to
prepare this solution over the course of the study and it was
stored at   4 C for less than 1 week. There was no evidence of
degradation during the 1 week storage period since ginsenos-
ide is stable in pH 7.0 water solution but unstable in acid
solution. The concentration is determined by weight per
volume. Components of American ginseng present in the
solution include the most water- soluble parts (Ginsenoside Ro,
Rb1, Re, Rg1, Rg2, Rg3, Rf, quinquenoside R1, gypenosede
X1 and water soluble material, Vitamins and metals as well as
undefined elements) (31,32).
Cell Culture
Rat pancreatic b cell derived cell line, INS-1, was a gift from
Dr Claes Wollheim (Centre Me ´dical Universitaire, Geneva,
Switzerland). INS-1 was cultured in 24-well cell culture plates
(Corning , St Louis, MO) for insulin assay and 4-well culture
slides (Lab-Tek
TM Chamber slide
TM system, Rochester, NY)
for immunohistochemistry. Cells were cultured in RPMI-1640
with 10% fetal bovine serum and 50 mM 2-mercaptoethanol to
maintain differentiation. Semi-confluent (80–90%) monolayer
cells in 100 mm polystyrene dishes (Becton Dickinson,
Lincoln Park, New Jersey) and 15–40 passage cells were
used for the experiments. IL-1b (200 pg ml
 1) was added to
cell cultures to induce cell apoptosis.
Fluorescence Immunohistochemistry
Cells were washed with phosphate-buffered saline (PBS) twice
and fixed with fixation solution (acetone:methanol:dH2O) for
20 min at room temperature (RT). Slides were then blocked
with 1% normal goat serum for 10 min at RT and incubated
with primary insulin antibody (mouse monoclonal anti-insulin
1:30 in PBS-T) at RT for 2 h. The slides were washed with
PBS-T three times and anti-mouse second antibody (Texas
Red Anti-Mouse 1:200) was then applied for 20 min. After the
second antibody, the slides were washed with PBS-T five
times and DAPI was added (for nuclei staining; Vector Labs,
Burlingame, CA). Finally, the slides were covered with
cover glass.
Tunel Staining (Apoptosis Test)
The detection of apoptotic nuclei using the TdT-mediated
dUTP nick-end labeling (TUNEL) method was performed
with ApoAlert
TM DNA Fragmentation Assay Kit (Clontech,
Palo Alto, CA). Briefly, cells were fixed in 3% paraformal-
dehyde and incubated in 0.3% H2O2 in methanol for 5 min to
block endogenous peroxidase. The slides were then incubated
with fluorescent-conjugated avidin in PBS for 2 h at RT.
After three washes, slides were coverslipped with glycerol-
phosphate buffer. Apoptotic cells were counted in at least
10 random fields and expressed as a percentage of the total cell
number (apoptotic index).
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The Enliten
TM ATP Assay system with a bioluminescence
detection kit (Promega Madison, WI) was used for ATP
measurement. The principle of the assay is that luciferase from
Photinus pyralis catalyses d-luciferin in the presence of ATP
and oxygen to oxyluciferin, Pi, AMP, carbon dioxide and light.
As described above, cells after removal or removal/incubation
were transferred to 1.5 ml Eppendorf tubes with 50 ml TCA
(5%) and immediately homogenated with a plastic homo-
genizer. The suspension was spun at 2000 r.p.m. and the
supernatant stored at  80 C until assay. ATP was measured
according to the kit protocol. Briefly, samples were neutralized
to pH 7.4 with 10 ml 4 M Tris and 10 ml added to a new tube
with 90 ml ATP-free water. The luciferase reagent was added
1 s before a 5 s measurement in the luminometer, as suggested
by the supplier. Light photons were measured by a lumino-
meter and were compared with an ATP standard curve to
calculate ATP concentration (33). Protein content in the
supernatant was determined with a spectrophotometric Pro-
tein Assay Kit (Pierce, Rockford, IL). The ATP level was
standardized by divided protein content. ATP content is
expressed in micromolar.
Enzyme-Linked Immunosorbent Assay for
Insulin Measurement
Insulin concentrations in the specimen (culture medium and
cell extracts) were measured using Ultra Sensitive Rat Insulin
ELISA Kit (Crystal Chem Inc., Downer Grove, IL) according
to the vendor’s instruction. The collected culture medium was
used to perform insulin assay. The cell extracts were extracted
using 5% TCA then neutralized with 4 M Tris buffer. Briefly,
insulin standards and appropriately diluted (1:50) samples
were added to an insulin antibody-coated 96-well microplate
and incubated for 2 h at 4 C. After washing five times, anti-rat
insulin enzyme conjugate was added to the well and incubated
for 30 min at RT. After washing seven times, an enzyme
substrate solution was added and then incubated up to 45 min
at RT in the dark. The reaction was halted by adding 1 N
sulfuric acid. Absorbance at 450 nm was read with a mQuant
microplate reader (Bio-Tek Instruments, Inc., Winooski, VT)
and concentrations were calculated by KC Junior  microplate
reader software (Bio-Tek Instruments, Inc.).
Western Blotting Analysis
Pancreatic b cells (INS-1) were plated in a monolayer at
10
6cellsml
 1on 35·10 mm plates.The protein was extracted
with lysis buffer (0.5% NP-40, 10 mM Tris, 10 mM NaCl,
1 mM EDTA and protease inhibitor 2 mM AEBSF, 0.13 mM
Bestatin, 1 mM leupeptin, 0.3 mM Aprotinin) and equal
amounts of protein were loaded on to 15–20% SDS–PAGE.
After electrophoresis (200 V for 45 min), the proteins were
transferred onto a nitrocellulose membrane for 2 h in a transfer
buffer (25 mM Tris, pH 8.3, 192 mM glycine and 20%
methanol). The nitrocellulose membrane was incubated with
1:1000 rabbit anti-caspase-9 antibody (Santa Cruz, CA), Bcl-2
antibody or primary UCP-2 antibody (Anti-Rabbit monoclone
antibody, Alpha-Diagnostic Intl, San Antonio, TX) in PBS-T
(PBS–0.5% Tween 20) containing 5% non-fat dry milk at 4 C
for 24 h. The membrane was then washed and incubated with a
second antibody coupled with horseradish peroxidase diluted
to 1:2000 in PBS-T at RT for at least 2 h. The primary antibody
immunoreaction was detected by incubating the membrane
with an enhanced chemiluminescence (ECL) kit (Amersham,
Piscataway, NJ) for 5 min. The membrane was then exposed
to Kodak film that captured the signal. The nitrocellulose
membranes were stripped with anti-actin antibody
(Sigma-Aldrich, St Louis, MO). Analysis of the immunoreac-
tions was carried out using specialized imaging software (NIH
image analysis system) and computer equipment from the
Central Research Facility at Rhode Island Hospital. The results
were normalized by actin signal.
Statistical Analysis
All the data are represented as means ± SEM and analyzed
by analysis of variance (ANOVA) followed by the
Tukey–Kramer test unless otherwise indicated.
Results
American Ginseng Increases Pancreatic B Cell Insulin
Secretion/Production and Cell Survival
The effect of American ginseng was observed to be
dosage-dependent on both insulin levels and apoptosis.
In situ imaging results show that American ginseng extracts
in b cell culture increased insulin positive cells as well as
prevented IL-1b (200 pg ml
 1) induced apoptosis (Fig. 1A).
An apoptotic detection kit (TUNEL ASSAY) was used to
detect IL-1b induced apoptosis in b cells, which clearly
showed the pro-apoptotic effects of IL-1b in cultures and
American ginseng extract was able to prevent IL-1b induced b
cell apoptosis (Fig. 1B).
Quantifying Insulin Production/Secretion
American ginseng was able to increase the amount of
insulin-producing cells as indicated by Fig. 1A. Using
enzyme-linked immunosorbent assay (ELISA) to quantify the
amount of insulin in cultures [secretion/medium (2a) and
production/cell content (2b)] with or without American
ginseng extracts administered, it was found that cultures with
American ginseng extracts displayed significant increases in
insulin levels while cells administered with IL-1b exhibited
significant decreases in insulin, while American ginseng was
able to reverse IL-1b induced insulin reduction (Fig. 2).
Bcl-2 and caspase-9 Involved in American Ginseng
on Apoptosis
Pro-apoptotic protein caspase-9 and anti-apoptotic protein
Bcl-2 have been known to be major factors in the regulation
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proposed to be able to regulate pancreatic b cell apoptosis
through mediation of caspase-9 and Bcl-2 activation. Measure-
ment of the response of Bcl-2 and caspase-9 to American
ginseng extracts in cultures showed American ginseng
inducing a higher expression of Bcl-2 and preventing
activation of caspase-9 by western blotting. The determining
levels of caspase-9 (Fig. 3A) and Bcl-2 (Fig. 3A) in
cultures was quantified by densitometry analysis and normal-
ized by actin.
Decrease UCP-2 Levels
UCP-2 negatively mediates ATP production and causes
cell death.The effects of ginseng on UCP-2 levels were
investigated in order to see which factors American ginseng
affects to achieve cell longevity. The UCP-2 levels in cultures
with or without American ginseng extracts were measured by
western blotting. Cultures with American ginseng extracts
displayed a low expression of UCP-2 while cells with IL-
1b exhibited enhanced levels. American ginseng was able to
reverse the effects of IL-1b induced UCP-2 over-expression
(Fig. 4).
American Ginseng Enhances ATP Production
Cellular ATP levels are closely linked to insulin production
and mitochondrial function, which is regulated perhaps by
UCP-2. American ginseng was able to regulate UCP-2 levels,
possibly linked to mitochondrial ATP production. ATP levels
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Figure 1. Insulin cell staining and apoptosis: the results of immunohistochemistry and TUNEL assays showed that American ginseng extracts (5 mg ml
 1)
increases insulin producing cells (A) and also protected against IL-1b induced apoptosis (B). Although American ginseng extracts had a positive effect on the cells,
an over dosage (250 mg per 50 ml) showed little effect on apoptosis protection (A) while better effects were found to prevent IL-1b induced apoptosis (B). (n ¼ 12,
*P < 0.01 versus control, **P < 0.01 versus IL-1b 200 pg ml
 1.)
368 Inhibition of UCP-2 expression by American ginsengshowed an inverse correlation between UCP-2 and ATP in
response to ginseng treatment. Data showed American ginseng
to be an enhancer of ATP production under IL-1b induced
anti-ATP circumstance. ATP levels were drastically lowered
by IL-1b but American ginseng stimulated an increased output
of ATP (Fig. 5).
Discussion
Throughout history, the ginseng root has been used in its
water-extract form. Evaluation of the water soluble material
from ginseng in extracts could be beneficial in the attempt to
find ginseng’s biological activation. The main active compon-
ent in ginseng, which is responsible for ginseng’s medical
value, has been identified as glycoside. Other than the
glycosides, minor constituents include volatile oils (member
of vitamin B complex), manganese, vanadium, copper, cobalt,
fatty acids, amino acids, simple sugars and other carbohydrates
[Dixon, P. Ginseng. Gerald Duckworth & Co. Ltd (1976)].
Glycoside is a naturally occurring substance consisting of a
sugar and non-sugar moiety. A glycoside which produces froth
under agitation by reducing water surface tension is called a
saponin. A group of saponins in ginseng were named
ginsenosides, and were classified into subclasses Ro, Ra, Rb,
Rc, Rd, Re, Rf, Rg, and Rh. These ginsenosides were
differentiated based on their retention factor (Rf) values in
Effectsof American Ginseng on Insulin Content in
Pancreatic β- Cells Treated With or Without IL- β
0
500
1000
1500
2000
2500
3000
control ginseng IL-1 G+I
n
g
/
m
g
p
r
o
t
e
i
n *
*
**
B
IL-1β
Effects of American Ginseng on Insulin Release
fromPancreatic β-C e l l
0
50
100
150
200
control ginseng -1B G+I
n
g
/
m
L
*
*
**
A
IL-1β
Figure 2. ELISAwasusedto measureinsulinfromb cellsculturedwithIL-1b
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Figure 3. (A) Western blotting results indicate that the level of caspase-9
activation in cells induced by IL-1b was significantly reduced by American
ginseng extracts. (B) Western blotting results indicate that the level of Bcl-2
activation in cells induced by IL-1b was significantly increased by American
ginseng extracts. (G ¼ American ginseng 25 mg per 5 ml, n ¼ 3, *P < 0.05
versus control, **P < 0.01 versus IL-1 b.)
eCAM 2006;3(3) 369thin layer chromatography (TLC), which is the distance that
the ginsenosides travel up the TLC column (34). A range of
chemical components with biological activity including
ginsenosides, alkaloids, polypeptides and polysaccharides
have been isolated. By 1992, Liu and Xiao reported that
28 ginsenosides had been found in different parts of the
ginseng plant (35). The report summarized the range of effects
that ginsenoside had, which included cardio-protective,
immunomodulatory, anti-fatigue and hepato-protective effects
(36). Oriental ginseng can be distinguished from American
ginseng using ginsenoside profiles as the former contains
ginsenoside Rf while the latter does not (37). The anti-
hyperglycemic effects of the total ginsenosides extracted from
Chinese ginseng (TGCG) were evaluated in diabetic C57BL/
6J ob/ob mice. The results indicated that in a diabetic ob/ob
mouse model TGCG was endowed with significant anti-
hyperglycemic and anti-obesity properties (38). One ginsen-
oside component, Re was evaluated in the same animal model
and the anti-hyperglycemic effect had been found to be caused
by improving the muscle’s metabolism (39). No evaluation of
pancreatic function was reported in these studies. However,
ginsenoside components could potentially be substances
which improve the pancreatic islet function in creating the
anti-hyperglycemic effect.
Previous studies have revealed that American ginseng
lowers blood glucose in diabetic patients (5) and benefits
pancreatic b cell insulin production, secretion and prevents b
cell apoptosis (40). Data presented in the current project
suggest that the effect of American ginseng in stimulating
insulin production/secretion and anti-apoptosis is dosage
dependent, which indicates biological specificity of ginseng
extracts on b cells. A high dosage of ginseng reversed IL-
1b induced apoptosis (Fig. 1B), which suggests that high
dosage of American ginseng is required for healing/repairing
damaged b cells but not for normal cells (lesser effect of high-
dosage American ginseng on b cell apoptosis; see Fig. 1A).
Regulation of UCP-2 activation in the mitochondria could be
a major mechanism for the effects of American ginseng on b
cell function. Elevations of UCP-2 levels were observed under
an IL-1b cytokine induced pancreatic b cell dysfunction model
(Fig. 4). UCP-2, a protein belonging to the large family of the
anion mitochondrial transporters, is believed to negatively
regulate metabolism. The uncoupling protein family consists
of three main uncoupling proteins. UCP-1 is well understood
and characterized as an uncoupler in brown adipocytes and
controls heat production. UCP-2 and 3 are not well known but
are proposed as ancestors of UCP-1. The role of UCP ancestral
functions was to facilitate the adaptation of cells to oxygen
through uncoupling of respiration. It is believed that UCP-2 is
linked to anti-hyperinsulinemia after the presence of the UCP-
2 gene was detected in pancreatic b cells (26). Potassium
channels are uncoupled by UCP-2 upon the inner membrane of
the mitochondria, relieving the osmotic proton pressure via
alternative channels (25). It is known that the ATP/ADP ratio
controls insulin secretion, which could be through the
inhibition of mitochondrial UCP-2 expression. UCP-2 levels
in relation to ATP and insulin production were observed by the
over expression of UCP-2 inhibited insulin secretion and
increased ATP levels. An inhibition of UCP-2 production
reversed results (26). In this study, we found that IL-
1b significantly increased UCP-2 expression, which was
UCP-2
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Figure 4. Western blotting images (top) display the reverse regulatory effects
of American ginseng on IL-1b induced pro-activation of UCP-2. Densitometry
analysis indicates there is significance between control and variable groups
(see graph). (G ¼ American ginseng 25 mg per 5 ml, n ¼ 3, *P < 0.05 versus
control, **P < 0.01 versus IL-1b 200 pg ml
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Figure 5. Bio-luminescence ATP data displays ginseng’s ability to counteract
IL-1b caused ATP effects. Administration of American ginseng increased
ATP generation and also increased insulin synthesis (see Fig. 2) and inhibited
UCP-2 levels in the mitochondria (see Fig. 4). (G ¼ American ginseng
25 mg per 5 ml, n ¼ 3, *P < 0.01 versus control, **P < 0.01 versus IL-1b
200 pg ml
 1.)
370 Inhibition of UCP-2 expression by American ginsengreversed by American ginseng root extracts accompanied by
an increase in ATP and insulin levelsin cultured bcells. This is
consistent with the ability of ATP in playing a critical
metabolic role that controls insulin secretion, and is mediated
primarily by UCP-2 (23). Thus, stimulation of insulin
synthesis and ATP production by American ginseng can be
achieved through the regulation of the mitochondria and
mitochondrial proteins, UCP-2, by affecting the ADP/ATP
ratio response.
Though little information and research shows the specific
role of UCP-2 on cell viability and longevity, cells with an
abnormally high UCP-2 level tend to exhibit a decrease in cell
livelihood (28). A major cause of shortened cell livelihood
would be the process of programmed cell death (apoptosis). A
model utilizing cytokine IL-1b to induce apoptosis provided a
platform for observing the effects of American ginseng on
apoptotic factors and overall apoptosis. Several protease
families are implicated in apoptosis, the most prominent being
caspases (18,19,41). Apoptosis is inhibited by the mitochon-
drial integral membrane protein Bcl-2, suggesting that the
mitochondria are a crucial mediator in the apoptosis process.
Bcl-2 inhibits the activation of the Caspase cascade by
suppressing the release of mitochondrial proteins (18). At the
commencement of the mitochondria-regulated apoptosis,
cytochrome c, a factor in electron transport is released from
the mitochondria, which leads to the activation of pro-caspase-
9, followed by activation of the entire cascade and nuclear
defragmentation (19).
In our studies, American ginseng extracts reversed IL-
1b induced increase of UCP-2 and pro-apoptotic protein
caspase-9 and reduced anti-apoptotic protein Bcl-2 and ATP
levels, indicating that the anti-apoptotic effects of American
ginseng could be achieved through regulating mitochondrial
UCP-2, ATP levels (Fig. 5) and apoptotic factors (caspase-9/
Bcl-2 Fig. 3), thus influencing insulin synthesis and apoptotic
cascades in b cells. It is the first study to show that American
ginseng root extracts can directly regulate the b cell
biochemical processes, which contribute to improving b cell
function with regard to insulin production and cell survival, all
of which may be directly connected to American ginseng’s
anti-hyperglycemic effects (Fig. 6). Further research is
required to fully understand the effects of American ginseng
extracts on pancreatic b cells and factors utilized by American
ginseng to achieve cell regulation and function. American
ginseng may enhance pancreatic b cell viability through
various alternative factors.
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